Cite
HARVARD Citation
Nelson, M. et al. (2016). Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning. Journal for immunotherapy of cancer. 4 (1), p. . [Online].